According to Merck's latest financial reports the company has $48.40 Billion USD in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $$46.37 B | 23.22% |
2023-12-31 | $$37.63 B | -18.29% |
2022-12-31 | $$46.05 B | 20.39% |
2021-12-31 | $$38.25 B | 50.59% |
2020-12-31 | $$25.40 B | -2.3% |
2019-12-31 | $$26.00 B | -3.28% |
2018-12-31 | $$26.88 B | -22.24% |
2017-12-31 | $$34.56 B | -14.24% |
2016-12-31 | $$40.30 B | -9.96% |
2015-12-31 | $$44.76 B | -8.25% |
2014-12-31 | $$48.79 B | -6.76% |
2013-12-31 | $$52.32 B | -5.66% |
2012-12-31 | $$55.46 B | -2.6% |
2011-12-31 | $$56.94 B | 0.24% |
2010-12-31 | $$56.80 B | -7.61% |
2009-12-31 | $$61.48 B | 190.47% |
2008-12-31 | $$21.16 B | 2.8% |
2007-12-31 | $$20.59 B | 3.13% |
2006-12-31 | $$19.96 B | -2.06% |
2005-12-31 | $$20.38 B | 3.5% |
2004-12-31 | $$19.69 B | 1.04% |
2003-12-31 | $$19.49 B | -15.73% |
2002-12-31 | $$23.12 B | 10.73% |
2001-12-31 | $$20.88 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $90.63 B | 87.27% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $78.10 B | 61.38% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $15.84 B | -67.26% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $17.44 B | -63.95% | ๐บ๐ธ USA |
![]() Sanofi SNY | $80.54 B | 66.42% | ๐ซ๐ท France |
![]() GlaxoSmithKline GSK | $17.66 B | -63.50% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $6.26 B | -87.05% | ๐ฎ๐ฑ Israel |
![]() Novartis NVS | $38.45 B | -20.55% | ๐จ๐ญ Switzerland |
![]() Abbott Laboratories ABT | $49.06 B | 1.37% | ๐บ๐ธ USA |
![]() Amgen AMGN | $6.20 B | -87.18% | ๐บ๐ธ USA |